Ara
Toplam kayıt 2, listelenen: 1-2
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less
(Lippincott Williams & Wilkins, 2017)
The objectives of this study were to compare progression-free survival (PFS) with somatostatin analog (SSA) versus chemotherapy (CTx) in first-line therapy and to determine the patient group in which these treatments were ...
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
(Galenos Yayincilik, 2016)
Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more aggressive than pure epithelial tumours, they are ...